Women’s and Providers’ Experiences with Injectable Contraceptives (Depo-Provera): A View from Vadodara, India
Keywords:
Clients’ and providers’, perspectives, depo-provera,, injectable contraceptives,, , India,, qualitative studyAbstract
Objective: To compare users’ and providers’ perspectives on injectable contraceptives (IC). Methods: This qualitative study
employed semi-structured in-depth interview technique. Sixty women with experience of using IC and 10 doctors involved
in providing IC were selected. Telephonic interviews of doctors were also conducted. Results: Over 50% of the women had
side effects and had discontinued use within 1 year. The most common ‘likes’ according to women included ease of use,
being tension free for 3 months and being effective and those of the providers were that it reduced anemia, privacy could be
maintained, noncontraceptive benefits, good substitute, not to be taken daily like pills, safe and effective. The most common
‘dislikes’ reported by providers and clients were excessive bleeding, amenorrhea, irregular periods, spotting, weight gain and
frequent pregnancy tests. Conclusion: Although certain distinct advantages of IC have been expressed, the associated problems
are equally significant and therefore IC should not be an over-the-counter contraceptive.
Downloads
Published
Issue
Section
License
All open access articles published in IJCP are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License). This license permits unrestricted use, distribution, and reproduction of the articles in any medium for non-commercial purposes, provided that: The original authorship is properly and fully attributed. The IJCP is cited as the original place of publication with correct citation details. If an original work is reproduced or disseminated in part or as a derivative work, this must be clearly indicated. No articles are reproduced for commercial use without prior consent from the IJCP. All licensing requests and permissions for commercial use will be managed by the Publisher.
